THERESA LONGO: Open Payments
NPI 1649354267 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,941 in 103 payments from 19 companies in 2025. Trend: 2023 $1,140 · 2024 $1,426 · 2025 $1,941
Food & beverage: $1,441Consulting: $500
| Company | Payments | Amount |
|---|---|---|
| Journey Medical Corporation | 2 | $511 |
| UCB, Inc. | 15 | $267 |
| ABBVIE INC. | 15 | $149 |
| Organon LLC | 14 | $149 |
| Galderma Laboratories, L.P. | 18 | $135 |
| Regeneron Healthcare Solutions, Inc. | 4 | $114 |
| MAYNE PHARMA COMMERCIAL LLC | 12 | $109 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $84 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| Amgen Inc. | 3 | $52 |
Products named: Bimzelx, SKYRIZI, VTAMA, DUPIXENT, NEMLUVIO, OTEZLA, CIBINQO, AKLIEF.
Industry payments across AZ — which companies pay providers there.
